Smith & Nephew (SNN) Depreciation & Amortization (CF) (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Depreciation & Amortization (CF) of $273.0 million for Q4 2024, down 4.55% year-on-year from $286.0 million in Q1 2024, and down 4.55% on a QoQ basis from $286.0 million in Q4 2023.
Smith & Nephew (SNN) Depreciation & Amortization (CF) (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $273.0 million the latest figure, recorded in Q4 2024.
- Quarterly Depreciation & Amortization (CF) fell 4.55% year-over-year to $273.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $273.0 million (down 68.55% YoY) and the FY2025 annual result came in at $573.0 million, down 11.16% from the prior year.
- Depreciation & Amortization (CF) fell to $273.0 million in Q4 2024 per SNN's latest filing, from $286.0 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for SNN reached as high as $309.0 million in Q4 2022 and fell as low as $271.0 million in Q4 2020.
- A 5-year average of $286.6 million and a median of $286.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) gained 9.27% — and 2023, when it retreated 7.44%.
- Year by year, Depreciation & Amortization (CF) stood at $271.0 million in 2020, then advanced by 8.49% to $294.0 million in 2021, then climbed by 5.1% to $309.0 million in 2022, then fell by 7.44% to $286.0 million in 2023, then declined by 4.55% to $273.0 million in 2024.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $273.0 million, $286.0 million, and $309.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 123.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 273.00 Mn |
| Dec 31, 2024 | 273.00 Mn |
| Dec 31, 2023 | 286.00 Mn |
| Dec 31, 2023 | 286.00 Mn |
| Dec 31, 2022 | 309.00 Mn |
| Dec 31, 2022 | 309.00 Mn |
| Dec 31, 2021 | 294.00 Mn |
| Dec 31, 2021 | 294.00 Mn |
| Dec 31, 2020 | 271.00 Mn |
| Dec 31, 2020 | 271.00 Mn |
| Dec 31, 2019 | 248.00 Mn |
| Dec 31, 2019 | 248.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2017 | 460.00 Mn |
| Dec 31, 2017 | 460.00 Mn |
| Dec 31, 2016 | 214.00 Mn |
| Dec 31, 2016 | 214.00 Mn |
| Dec 31, 2015 | 511.00 Mn |
| Dec 31, 2015 | 511.00 Mn |